TY - JOUR
T1 - Individualised dosing of amikacin in neonates
AU - Sherwin, Catherine M.T.
AU - Broadbent, Roland S.
AU - Medlicott, Natalie J.
AU - Reith, David M.
PY - 2009/12/1
Y1 - 2009/12/1
N2 - We thank van den Anker and Allegaert for their comments on our recent paper (1) regarding individualised dosing of amikacin in neonates. We are particularly pleased at the recognition given to the pharmacodynamic considerations, because this is where we consider the most mileage can to be made in improving aminoglycoside drug regimens.
AB - We thank van den Anker and Allegaert for their comments on our recent paper (1) regarding individualised dosing of amikacin in neonates. We are particularly pleased at the recognition given to the pharmacodynamic considerations, because this is where we consider the most mileage can to be made in improving aminoglycoside drug regimens.
UR - http://www.scopus.com/inward/record.url?scp=71249164315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71249164315&partnerID=8YFLogxK
UR - https://corescholar.libraries.wright.edu/pediatrics/348
U2 - 10.1007/s00228-009-0691-y
DO - 10.1007/s00228-009-0691-y
M3 - Letter
C2 - 19655134
AN - SCOPUS:71249164315
SN - 0031-6970
VL - 65
SP - 1267
EP - 1268
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
IS - 12
ER -